Edesa Biotech, Inc.
EDSA
$4.72
-$0.01-0.21%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -28.19% | -87.67% | -0.87% | -27.37% | -10.00% |
| Total Depreciation and Amortization | -1.16% | 1.57% | -1.54% | 0.39% | 5.31% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 12.91% | 21.26% | -1.11% | 127.96% | 165.97% |
| Change in Net Operating Assets | 3.60% | 738.11% | -443.71% | 149.90% | 82.52% |
| Cash from Operations | -52.87% | 3.39% | -21.28% | -1.19% | 28.64% |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -100.00% | 1,486.30% | -- | -100.00% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -100.00% |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -490.00% | 93.68% | -318.82% | -- | 100.00% |
| Cash from Financing | 38,398.89% | -100.27% | 1,699.14% | -- | -100.00% |
| Foreign Exchange rate Adjustments | -57.33% | -164.71% | 75.71% | -121.11% | 393.97% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 116.05% | -262.60% | 180.25% | -2.25% | -112.45% |